Category: transparency
Recent announcements by the US Food and Drug Administration and Congress suggest an impending regulatory crackdown on companies offering genetic information directly to consumers. In an article on Xconomy, Dan Vorhaus and I argue that the best way forward is not to bring in strong regulation, but rather to encourage the industry to move towards greater transparency.
Read on »
Posted by Daniel MacArthur at 7:30 AM • 3 Comments •
Category: consumer-driven research
After a year in review, a manuscript from direct-to-consumer genetic testing company 23andMe describing novel genetic associations obtained by mining their customer database has been published by PLoS Genetics.
Read on »
Posted by Daniel MacArthur at 6:30 AM • 9 Comments •
Category: personal genomics
Snippets of news from around the personal genomics world.
Read on »
Posted by Daniel MacArthur at 9:45 AM • •
It looks as though the FDA is swooping down on the direct-to-consumer genetic testing industry in a serious way, sending formal letters to five companies informing them that their tests will be regulated as medical devices:WASHINGTON -- The Food and...
Read on »
Posted by Daniel MacArthur at 11:45 AM • 32 Comments •
Category: errors
Personal genomics company 23andMe has revealed more details about the cause of its embarrassing sample mix-up last week, which resulted in the wrong data being returned to 96 customers.
Read on »
Posted by Daniel MacArthur at 7:30 PM • 7 Comments •
Some worthwhile recent links from the world of personal genomics: A great piece in Newsweek by Mary Carmichael summarising the recent regulatory furore over direct-to-consumer genetic testing, and the potential implications for the industry. Emily Singer has two articles at...
Read on »
Posted by Daniel MacArthur at 10:00 AM • 1 Comments •
Category: direct-to-consumer genetic testing
Personal genomics company 23andMe has revealed that it accidentally mixed up the samples from up to 96 customers, resulting in genetic data being returned to the wrong individuals. If the industry is to survive it needs to ensure these mistakes don't happen; but customers also need to play a role as watchdogs of their own genetic data.
Read on »
Posted by Daniel MacArthur at 6:00 AM • 31 Comments •
Category: next-generation sequencing
Sequencing giant Illumina has announced a stunning price drop for its retail whole-genome sequencing service. It's still not cheap, at $19,500, but it sets the scene for a price war that will ultimately benefit all of us interested in affordable genome sequencing.
Read on »
Posted by Daniel MacArthur at 7:00 PM • 5 Comments •
